Biomerieux Vitek, Inc.: FDA filings under this applicant name
FDA lists 49 510(k) clearances under the applicant name “Biomerieux Vitek, Inc.” (first 1992, latest 1998), plus 1 PMA decision, across 41 product codes in 6 review panels. Median 510(k) review time under this name: 148 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under bioMérieux, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| GJT | Plasma, Coagulation Factor Deficient | 5 | 5 |
| LGD | Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii | 3 | 3 |
| CHP | Radioimmunoassay, Estradiol | 2 | 2 |
| LIQ | Enzyme Linked Immunoabsorbent Assay, Rotavirus | 2 | 2 |
| LQL | Gram Positive Identification Panel | 2 | 2 |
| CDP | Radioimmunoassay, Total Triiodothyronine | 1 | 1 |
| CEC | Radioimmunoassay, Free Thyroxine | 1 | 1 |
| CFT | Radioimmunoassay, Prolactin (Lactogen) | 1 | 1 |
| CGJ | Radioimmunoassay, Follicle-Stimulating Hormone | 1 | 1 |
| DAP | Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control | 1 | 1 |
Plus 31 more product codes.
Review panels
- Microbiology (19)
- Hematology (15)
- Clinical Chemistry (12)
- Clinical Toxicology (2)
- Immunology (1)
- General and Plastic Surgery (1)
Most recent Biomerieux Vitek, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K973819 | VIDAS D-DIMER (DD) ASSAY | DAP | 1998-03-10 | 154 |
| K972895 | VIDAS ROTAVIRUS (RTV) ASSAY | LIQ | 1997-10-03 | 59 |
| K965092 | VIDAS ROTAVIRUS ASSAY | LIQ | 1997-05-05 | 137 |
| K964887 | VIDAS C. DIFFICILE TOXIN A II ASSAY | LLH | 1997-04-08 | 123 |
| K955627 | VIDAS CHLAMYDIA BLOCKING ASSAY | LJC | 1996-10-07 | 301 |
| K962609 | GRAM NEGATIVE IDENTIFICATION PLUS CARD | LRH | 1996-08-30 | 58 |
| K962549 | VIDAS CREATINE KINASE MB ASSAY 30-421 | JHX | 1996-08-30 | 63 |
| K952095 | VITEK GRAM POSITIVE IDENTIFICATION CARD (GPI) | LQL | 1996-03-12 | 313 |
| K955647 | VIDAS ESTRADIOL II (E2II) ASSAY | CHP | 1996-02-06 | 56 |
| K943812 | VIDAS LYME SCREEN II | LSR | 1995-06-13 | 312 |
39 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| N50510 | PMA | VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD | 1978-03-02 |
Recalls
FDA recall records list no recalls under a recalling firm named Biomerieux Vitek, Inc..
13 product recalls in 11 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 3 initiated in the last five years. Most often: Biomerieux Inc (5), bioMerieux, Inc. (5), BioMerieux SA (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Biomerieux Vitek, Inc. (a text match, not an official crosswalk):
- J7197 — Antithrombin iii (human), per i.u. (via JBQ)
- J7213 — Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. (via GJT)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- bioMerieux, Inc. (261 510(k)s)
- Biomerieux S.A. (16 510(k)s)
- Biomérieux SA (4 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Biomerieux Vitek, Inc.?
FDA lists 49 510(k) clearances under the applicant name “Biomerieux Vitek, Inc.” (first 1992, latest 1998), plus 1 PMA decision, across 41 product codes in 6 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Biomerieux Vitek, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Biomerieux Vitek, Inc. is 148 days.
Which FDA product codes appear under Biomerieux Vitek, Inc.?
The most frequent FDA product codes under this applicant name are GJT (Plasma, Coagulation Factor Deficient, 5); LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii, 3); CHP (Radioimmunoassay, Estradiol, 2).
Next steps
- See all 49 Biomerieux Vitek, Inc. clearances with predicates and recalls
- Run predicate analysis for product code GJT, Biomerieux Vitek, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.